These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


429 related items for PubMed ID: 17310821

  • 21. Overlap lamivudine treatment in patients with chronic hepatitis B receiving adefovir for lamivudine-resistant viral mutants.
    Liu CJ, Kao JH, Chen PJ, Chen TC, Lin FY, Lai MY, Chen DS.
    J Viral Hepat; 2006 Jun; 13(6):387-95. PubMed ID: 16842441
    [Abstract] [Full Text] [Related]

  • 22. Viral genotype and baseline load predict the response to adefovir treatment in lamivudine-resistant chronic hepatitis B patients.
    Buti M, Elefsiniotis I, Jardi R, Vargas V, Rodriguez-Frias F, Schapper M, Bonovas S, Esteban R.
    J Hepatol; 2007 Sep; 47(3):366-72. PubMed ID: 17561304
    [Abstract] [Full Text] [Related]

  • 23. Mutations associated with the therapeutic efficacy of adefovir dipivoxil added to lamivudine in patients resistant to lamivudine with type B chronic hepatitis.
    Ohkawa K, Takehara T, Kato M, Kanada A, Deguchi M, Kagita M, Hikita H, Sasakawa A, Kohga K, Uemura A, Sakamori R, Yamaguchi S, Miyagi T, Ishida H, Tatsumi T, Hayashi N.
    J Med Virol; 2009 May; 81(5):798-806. PubMed ID: 19319954
    [Abstract] [Full Text] [Related]

  • 24. Evolution of full-length HBV sequences in chronic hepatitis B patients with sequential lamivudine and adefovir dipivoxil resistance.
    Chen CH, Lee CM, Tung WC, Wang JH, Hung CH, Hu TH, Wang JC, Lu SN, Changchien CS.
    J Hepatol; 2010 Apr; 52(4):478-85. PubMed ID: 20185198
    [Abstract] [Full Text] [Related]

  • 25. Virologic responses to add-on adefovir dipivoxil treatment versus entecavir monotherapy in children with lamivudine-resistant chronic hepatitis B.
    Chu M, Cho SM, Choe BH, Cho MH, Kwon S, Lee WK.
    J Pediatr Gastroenterol Nutr; 2012 Dec; 55(6):648-52. PubMed ID: 22688509
    [Abstract] [Full Text] [Related]

  • 26. Safety and efficacy of adefovir therapy for lamivudine-resistant hepatitis B virus infection in renal transplant recipients.
    Lai HW, Chang CC, Chen TH, Tsai MC, Chen TY, Lin CC.
    J Formos Med Assoc; 2012 Aug; 111(8):439-44. PubMed ID: 22939662
    [Abstract] [Full Text] [Related]

  • 27. Adefovir plus lamivudine are more effective than adefovir alone in lamivudine-resistant HBeAg- chronic hepatitis B patients: a 4-year study.
    Vassiliadis TG, Giouleme O, Koumerkeridis G, Koumaras H, Tziomalos K, Patsiaoura K, Grammatikos N, Mpoumponaris A, Gkisakis D, Theodoropoulos K, Panderi A, Katsinelos P, Eugenidis N.
    J Gastroenterol Hepatol; 2010 Jan; 25(1):54-60. PubMed ID: 19780875
    [Abstract] [Full Text] [Related]

  • 28. Rescue monotherapy in lamivudine-resistant hepatitis B e antigen-positive chronic hepatitis B: adefovir versus entecavir.
    Lee JM, Kim HJ, Park JY, Lee CK, Kim DY, Kim JK, Lee HW, Paik YH, Lee KS, Han KH, Chon CY, Hong SP, Nguyen T, Ahn SH.
    Antivir Ther; 2009 Jan; 14(5):705-12. PubMed ID: 19704174
    [Abstract] [Full Text] [Related]

  • 29. Simple scoring system predicting genotypic resistance during rescue therapy for Lamivudine-resistant chronic hepatitis B.
    Lee JH, Yoon JH, Cho EJ, Yang HJ, Jang ES, Kwak MS, Hwang SY, Yu SJ, Lee CH, Kim YJ, Kim CY, Lee HS.
    J Clin Gastroenterol; 2012 Mar; 46(3):243-50. PubMed ID: 21716122
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. rtL180M mutation of hepatitis B virus is closely associated with frequent virological resistance to adefovir dipivoxil therapy.
    Lee YS, Chung YH, Kim JA, Jin YJ, Park WH, Kim SE, Lee D, Shim JH, Kim KM, Lim YS, Lee HC, Lee YS, Suh DJ.
    J Gastroenterol Hepatol; 2012 Feb; 27(2):300-5. PubMed ID: 21777282
    [Abstract] [Full Text] [Related]

  • 33. Long-term therapy with adefovir dipivoxil in hepatitis B e antigen-negative patients developing resistance to lamivudine.
    Manolakopoulos S, Bethanis S, Koutsounas S, Goulis J, Vlachogiannakos J, Christias E, Saveriadis A, Pavlidis C, Triantos C, Christidou A, Papatheodoridis G, Karamanolis D, Tzourmakliotis D.
    Aliment Pharmacol Ther; 2008 Feb 01; 27(3):266-73. PubMed ID: 17988233
    [Abstract] [Full Text] [Related]

  • 34. HBV DNA level at 24 weeks is the best predictor of virological response to adefovir add-on therapy in patients with lamivudine resistance.
    Shin JW, Jung SW, Park BR, Kim CJ, Eum JB, Kim BG, Du Jeong I, Bang SJ, Park NH.
    Antivir Ther; 2012 Feb 01; 17(2):387-94. PubMed ID: 22293395
    [Abstract] [Full Text] [Related]

  • 35. [A clinical study of adefovir dipivoxil in treating lamivudine refractory HBeAg-positive chronic hepatitis B].
    Zhao H, Zhang YX, Chen XY, Wang L, Tang XP, Si CW.
    Zhonghua Nei Ke Za Zhi; 2007 Apr 01; 46(4):294-7. PubMed ID: 17637268
    [Abstract] [Full Text] [Related]

  • 36. Clonal analysis of the quasispecies of antiviral-resistant HBV genomes in patients with entecavir resistance during rescue treatment and successful treatment of entecavir resistance with tenofovir.
    Karatayli E, Idilman R, Karatayli SC, Cevik E, Yakut M, Seven G, Kabaçam G, Bozdayi AM, Yurdaydin C.
    Antivir Ther; 2013 Apr 01; 18(1):77-85. PubMed ID: 22878399
    [Abstract] [Full Text] [Related]

  • 37. Virologic response and resistance to adefovir in patients with chronic hepatitis B.
    Fung SK, Chae HB, Fontana RJ, Conjeevaram H, Marrero J, Oberhelman K, Hussain M, Lok AS.
    J Hepatol; 2006 Feb 01; 44(2):283-90. PubMed ID: 16338024
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Early virological suppression is associated with good maintained response to adefovir dipivoxil in lamivudine resistant chronic hepatitis B.
    Chan HL, Wong VW, Tse CH, Chim AM, Chan HY, Wong GL, Sung JJ.
    Aliment Pharmacol Ther; 2007 Apr 15; 25(8):891-8. PubMed ID: 17402992
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 22.